白血病·淋巴瘤
白血病·淋巴瘤
백혈병·림파류
JOURNAL OF LEUKEMIA & LYMPHOMA
2011年
11期
672-675,679
,共5页
侯淑玲%张巧花%王军%贺建霞%郭素堂
侯淑玲%張巧花%王軍%賀建霞%郭素堂
후숙령%장교화%왕군%하건하%곽소당
淋巴瘤%光谱法,质量,基质辅助激光解吸电离%血清%蛋白组学模式%生物标志物
淋巴瘤%光譜法,質量,基質輔助激光解吸電離%血清%蛋白組學模式%生物標誌物
림파류%광보법,질량,기질보조격광해흡전리%혈청%단백조학모식%생물표지물
Lymphoma%Spectrometry,mass,matrix-assisted laser desorption-ionization%Serum%Proteomic patterns%Biomarker
目的 应用蛋白质组学表面增强激光解吸电离-飞行时间-质谱( SELDI-TOF-MS)技术筛选淋巴瘤患者血清特异性生物标志物,发现淋巴瘤早期诊断与人群筛查的血清学特异性标志.方法 应用SELDI-TOF-MS技术检测96例淋巴瘤患者血清特异性标志物,包括非霍奇金淋巴瘤(NHL) 86例,霍奇金淋巴瘤( HL) 10例,以30名健康体检者作为对照.采用生物化学法测定乳酸脱氢酶(LDH),酶联免疫吸附法( ELISA)测定可溶性白细胞介素-2受体(sIL-2R)、β2-微球蛋白(β2-MG)和糖链抗原125( CA125).结果 在质荷比(M/Z)为0.2~16.0间,NHL患者有15个蛋白质含量与健康人差异有统计学意义(P<0.01),其中M/Z为6880、8564、8692和13751的蛋白质低表达对淋巴瘤的敏感度与特异度高,灵敏度和特异度分别为82.29%和80.00%、78.13%和73.30%、75.00%和80.00%、71.88%和83.30%.4个蛋白质对淋巴瘤诊断的灵敏度与特异度差异均无统计学意义(P>0.05),4个蛋白质联合检测淋巴瘤特异度达100.00%,与LDH的灵敏度21.74%、CA125的灵敏度56.80%、β2-MG的灵敏度70.50%比较,差异均有统计学意义(P<0.05).结论 对M/Z为6880、8564、8692和13751的蛋白质行质谱检测,有望作为人群筛查、诊断淋巴瘤的血清学特异性标志.
目的 應用蛋白質組學錶麵增彊激光解吸電離-飛行時間-質譜( SELDI-TOF-MS)技術篩選淋巴瘤患者血清特異性生物標誌物,髮現淋巴瘤早期診斷與人群篩查的血清學特異性標誌.方法 應用SELDI-TOF-MS技術檢測96例淋巴瘤患者血清特異性標誌物,包括非霍奇金淋巴瘤(NHL) 86例,霍奇金淋巴瘤( HL) 10例,以30名健康體檢者作為對照.採用生物化學法測定乳痠脫氫酶(LDH),酶聯免疫吸附法( ELISA)測定可溶性白細胞介素-2受體(sIL-2R)、β2-微毬蛋白(β2-MG)和糖鏈抗原125( CA125).結果 在質荷比(M/Z)為0.2~16.0間,NHL患者有15箇蛋白質含量與健康人差異有統計學意義(P<0.01),其中M/Z為6880、8564、8692和13751的蛋白質低錶達對淋巴瘤的敏感度與特異度高,靈敏度和特異度分彆為82.29%和80.00%、78.13%和73.30%、75.00%和80.00%、71.88%和83.30%.4箇蛋白質對淋巴瘤診斷的靈敏度與特異度差異均無統計學意義(P>0.05),4箇蛋白質聯閤檢測淋巴瘤特異度達100.00%,與LDH的靈敏度21.74%、CA125的靈敏度56.80%、β2-MG的靈敏度70.50%比較,差異均有統計學意義(P<0.05).結論 對M/Z為6880、8564、8692和13751的蛋白質行質譜檢測,有望作為人群篩查、診斷淋巴瘤的血清學特異性標誌.
목적 응용단백질조학표면증강격광해흡전리-비행시간-질보( SELDI-TOF-MS)기술사선림파류환자혈청특이성생물표지물,발현림파류조기진단여인군사사적혈청학특이성표지.방법 응용SELDI-TOF-MS기술검측96례림파류환자혈청특이성표지물,포괄비곽기금림파류(NHL) 86례,곽기금림파류( HL) 10례,이30명건강체검자작위대조.채용생물화학법측정유산탈경매(LDH),매련면역흡부법( ELISA)측정가용성백세포개소-2수체(sIL-2R)、β2-미구단백(β2-MG)화당련항원125( CA125).결과 재질하비(M/Z)위0.2~16.0간,NHL환자유15개단백질함량여건강인차이유통계학의의(P<0.01),기중M/Z위6880、8564、8692화13751적단백질저표체대림파류적민감도여특이도고,령민도화특이도분별위82.29%화80.00%、78.13%화73.30%、75.00%화80.00%、71.88%화83.30%.4개단백질대림파류진단적령민도여특이도차이균무통계학의의(P>0.05),4개단백질연합검측림파류특이도체100.00%,여LDH적령민도21.74%、CA125적령민도56.80%、β2-MG적령민도70.50%비교,차이균유통계학의의(P<0.05).결론 대M/Z위6880、8564、8692화13751적단백질행질보검측,유망작위인군사사、진단림파류적혈청학특이성표지.
Objective To identify serum specific protein biomarkers for the early diagnosis of lymphoma patients by using surface enhanced laser desorption/ionization time of flight mass spectrometry (SELDI-TOF-MS) protein chip array.Methods SELDI-TOF-MS technique and weak cation exchanger (WCX2) protein chip were used to detect the serum proteomic patterns of 96 patients with lymphoma (86 patients with non-Hodgkin lymphoma and 10 patients with Hodgkin lymphoma) and 30 normal control.The serum level of LDH were measured by biochemical methods,the serum level of β2-MG and CA125 were detected by enzyme-linked immunosorbent assay (ELISA).Results Four protein peaks pattern mass/charge ratio (M/Z) 6880,8564,8692 and 13751 were decreased in lymphoma patients,and they could be used to distinguish lymphoma from healthy people and other malignant tumors.Their sensitivity and specificity were 82.29 % and 80.00 %,78.13 % and 73.30 %,75.00 % and 80.00 %,71.88 % and 83.30 % respectively in lymphoma patients.When it was used to early diagnosing lymphoma in stage Ⅰ or Ⅱ,the sensitivity of four protein peaks pattern (M/Z 6880,8564,8692 and 13 751) were 77.55 %,71.43 %,71.43 % and 67.35 %respectively and the specificity of all four protein peaks pattern were 100.00 %.Four protein peaks pattern sensitivity were higher than LDH,CA125 and β2-MG respectively.Conclusion Application of SELDI-TOF-MS can be of great potential for the early diagnosis of lymphoma patients.